Taj Mohammad

About

Dr. Taj Mohammad is a National Postdoctoral Fellow working as a Principal Investigator on an ANRF-funded project at the All India Institute of Medical Sciences (AIIMS), New Delhi, India. His research focuses on genomic and proteomic analyses of complex diseases, disease modeling, structure-based drug discovery, and next-generation sequencing (NGS) analytics. Currently, he is dedicated to making bioinformatics more accessible to non-computational scientists by developing intuitive GUI platforms for drug discovery and multi-omics data analysis.

Dr. Mohammad completed his M.Phil. in Interdisciplinary Research and Ph.D. in Biological Sciences (Prostate cancer) under the mentorship of Prof. Md. Imtaiyaz Hassan at Jamia Millia Islamia, New Delhi

Employment

• Jamia Millia Islamia

Education

• Jamia Millia Islamia Ph.D. (Interdisciplinary Research in Basic Sciences)
  2016 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (111)

• Structure-based drug repurposing reveals ponatinib and lapatinib as stable inhibitors of Aurora kinase B: Mechanistic insights from high-resolution molecular dynamics and free-energy analyses
  Computational Biology and Chemistry 2026 DOI: 10.1016/j.compbiolchem.2026.109034
  +Save
• Global, regional, and national burden of road injuries 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet. Public Health 2026 DOI: 10.1016/S2468-2667(26)00141-6
  +Save
• Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet Infectious Diseases 2026 DOI: 10.1016/S1473-3099(26)00295-1
  +Save
• Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
  The Lancet Infectious Diseases 2026 DOI: 10.1016/S1473-3099(26)00194-5
  +Save
• Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet 2026 DOI: 10.1016/S0140-6736(26)00519-2
  +Save
• Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet Infectious Diseases 2026 DOI: 10.1016/S1473-3099(25)00689-9
  +Save
• Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet Oncology 2026 DOI: 10.1016/S1470-2045(25)00730-2
  +Save
• Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  The Lancet. Neurology 2026 DOI: 10.1016/S1474-4422(26)00101-8
  +Save
• Phytochemicals as potential AXL inhibitors for cancer therapy: A computational study
  Computational Biology and Chemistry 2026 DOI: 10.1016/j.compbiolchem.2025.108636
  +Save
• Identification of FDA-Approved Drugs as Potential Inhibitors of WEE2: Structure-Based Virtual Screening and Molecular Dynamics with Perspectives for Machine Learning-Assisted Prioritization
  Life 2026 DOI: 10.3390/life16020185
  +Save